(Q36728361)

15 August 2017

Trial design challenges when combining medication and parent training in children with pervasive developmental disorders (English)

1 reference

15 August 2017

1

1 reference

15 August 2017

Christopher J McDougle

3

object named as

Christopher J McDougle

1 reference

15 August 2017

Denis Sukhodolsky

10

0 references

L Eugene Arnold

4

object named as

L Eugene Arnold

1 reference

15 August 2017

11

Naomi Swiezy

1 reference

15 August 2017

17

Benedetto Vitiello

1 reference

15 August 2017

8

James Dziura

1 reference

15 August 2017

2

Michael G Aman

1 reference

15 August 2017

6

Benjamin Handen

1 reference

15 August 2017

7

Cynthia Johnson

1 reference

15 August 2017

14

Karen Bearss

1 reference

15 August 2017

13

Kimberly Stigler

1 reference

15 August 2017

9

Eric Butter

1 reference

15 August 2017

12

James Mulick

1 reference

15 August 2017

James T McCracken

5

1 reference

15 August 2017

Louise Ritz

15

1 reference

15 August 2017

Ann Wagner

16

1 reference

15 August 2017

language of work or name

English

0 references

publication date

19 December 2008

1 reference

Journal of Autism and Developmental Disorders

15 August 2017

1 reference

15 August 2017

39

1 reference

15 August 2017

5

1 reference

15 August 2017

720-729

1 reference

https://scigraph.springernature.com/pub.10.1007/s10803-008-0675-2

15 August 2017

0 references

cites work

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Designing research studies on psychosocial interventions in autism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

30 September 2017

The prevalence of autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Risperidone in children with autism and serious behavioral problems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Intensive behavioral/psychoeducational treatments for autism: research needs and future directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Review of adaptive behavior studies in mentally retarded persons with autism/pervasive developmental disorder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Behavioral treatment and normal educational and intellectual functioning in young autistic children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Risperidone and adaptive behavior in children with autism.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Parent-directed, intensive early intervention for children with pervasive developmental disorder.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4807607

Mediation in experimental and nonexperimental studies: New procedures and recommendations

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19096921

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19096921

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10803-008-0675-2

1 reference

15 August 2017

1 reference

15 August 2017

1 reference